Healx, an Accelerate Cambridge startup focusing on identifying next-generation drug repositioning opportunities for rare diseases, has just closed a £300k seed round and hired some star entrepreneurs in science and technology to help with the next phase of growth.
Read the full article [businessweekly.co.uk]
Comments